Radiotheranostics With Nanoparticles: Precision Targeting in Receptor-Overexpressing Tumors.

Cheruiyot EJ, Wanjeh DM, Birir JK, Karuga SW, Amugune BK, Chambers CG, Lewis MR, Smith CJ, Sakr TM

DOI: 10.1002/jlcr.70028
Published: 2026 Apr
Container: Journal of labelled compounds & radiopharmaceuticals
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jlcr.70028,
  title = {Radiotheranostics With Nanoparticles: Precision Targeting in Receptor-Overexpressing Tumors.},
  author = {Cheruiyot EJ and Wanjeh DM and Birir JK and Karuga SW and Amugune BK and Chambers CG and Lewis MR and Smith CJ and Sakr TM},
  year = {2026},
  journal = {Journal of labelled compounds \& radiopharmaceuticals},
  doi = {10.1002/jlcr.70028},
  url = {https://doi.org/10.1002/jlcr.70028}
}

RIS

TY  - JOUR
TI  - Radiotheranostics With Nanoparticles: Precision Targeting in Receptor-Overexpressing Tumors.
AU  - Cheruiyot EJ
AU  - Wanjeh DM
AU  - Birir JK
AU  - Karuga SW
AU  - Amugune BK
AU  - Chambers CG
AU  - Lewis MR
AU  - Smith CJ
AU  - Sakr TM
PY  - 2026
JO  - Journal of labelled compounds & radiopharmaceuticals
DO  - 10.1002/jlcr.70028
UR  - https://doi.org/10.1002/jlcr.70028
ER  -

APA

EJ, C., DM, W., JK, B., SW, K., BK, A., CG, C., MR, L., CJ, S., & TM, S. (2026). Radiotheranostics With Nanoparticles: Precision Targeting in Receptor-Overexpressing Tumors.. Journal of labelled compounds & radiopharmaceuticals. https://doi.org/10.1002/jlcr.70028

Source records

pubmed · retrieved 2026-09-26T14:07:38.530Z